Invesaro

Stocks TRUP Financial statements

Financial statements

TRUPANION, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TRUPANION, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1882433043845026999051,1091,2861,439
Cost of revenue2533194205957839781,1071,208
Gross profit33.343.151.464.981.9104122131179231
Selling and marketing15.219.12535.547.878.689.577.471.485.4
General and administrative15.216.817.118.421.831.939.460.263.776.6
Operating expenses4045.752.466.586.7139165171188217
Operating income-6.7-2.64-1.05-1.92-4.93-35.2-43-40.7-9.5113.8
Interest expense0.220.531.21.351.380.014.2712.114.513.8
Interest income0.10.20.91.70.60.33912.412.3
Other non-operating income0.061.241.311.630.58-0.013.077.714.421.9
Pre-tax income-6.86-1.93-0.93-1.64-5.73-35.2-44.2-45-9.6422
Income tax0.04-0.43-0.010.170.110.310.48-0.34-0.012.56
Net income-6.9-1.5-0.93-1.81-5.84-35.5-44.7-44.7-9.6319.4
EBITDA-2.851.593.473.712.14-23.2-32.1-28.26.9529.7
EPS, basic-0.24-0.05-0.03-0.05-0.16-0.89-1.10-1.08-0.230.45
EPS, diluted-0.24-0.05-0.03-0.05-0.16-0.89-1.10-1.08-0.230.45
Shares, basic (weighted)28.529.63234.635.940.140.841.442.243
Shares, diluted (weighted)28.529.63234.635.940.140.841.442.243.6

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents23.625.726.629.214087.465.6148160138
Short-term investments29.637.654.669.789.9126157130147233
Total current assets65.486.6118159337391469562597691
Property, plant and equipment8.467.8769.870.472.67890.7104102105
Lease right-of-use assets0.10.90.80.3614.7
Goodwill03332.74243.73739.4
Intangible assets4.914.978.077.7327.122.72418.713.224.1
Long-term investments2.583.243.554.325.577.067.8412.90.370.98
Other non-current assets0.132.626.7114.616.617.818.918.917.621.2
Total assets82.3106208257498563672783807915
Accounts payable2.012.722.774.096.068.959.4710.511.516.4
Accrued liabilities5.427.6611.313.822.928.232.634.133.556.5
Deferred revenue13.522.73352.592.5147203235252271
Short-term debt01.11.351.3510
Total current liabilities30.445.963.291.6150224290344350410
Long-term debt4.779.3212.926.10068.4128128102
Lease liabilities0.3613.4
Other non-current liabilities0.831.231.271.613.213.864.974.494.4818
Total liabilities37.657.478.3120158230366479484531
Total debt4.779.3212.926.10068.4128128102
Paid-in capital130135220233439467500536568605
Retained earnings-81.3-82.8-83.7-85.5-91.4-127-172-216-226-206
Treasury stock-3.2-3.2-6.2-10.7-10.8-10.8-16.5-16.5-16.5-16.5
Other comprehensive income-0.38-0.09-0.750.253.073.08-6.30.4-2.612.1
Shareholders' equity44.748.4129137340332305304323384
Total equity44.748.4129137340332305304323384
Total liabilities and equity82.3106208257498563672783807915
Shares outstanding29.530.13434.939.540.54141.942.543.4

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-6.9-1.5-0.93-1.81-5.84-35.5-44.7-44.7-9.6319.4
Depreciation and amortization3.854.234.515.637.071210.912.516.515.8
Stock-based compensation2.953.424.786.858.9128.233.433.233.438.3
Deferred income tax0-0.63-0.030.11-0.13-1.81-0.42-0.8-0.74-0.58
Change in receivables-1.83-10.2-11.2-22.8-43.3-66.2-67-35.4-6.72-27.2
Change in payables1.163.024.534.119.958.83.141.642.0826
Cash from operations5.019.6712.716.221.57.46-818.648.389.5
Capital expenditures-1.94-3.13-56.9-5.37-7.45-12.4-17.1-18.3-9.72-14.1
Acquisitions0-48.10-1500
Sales and maturities of investments04311577.1142
Cash from investing-6.51-13.1-81.5-28-76.7-51.9-67.57.64-13.5-95.9
Debt repaid00-100-32.50-0.57-1.72-1.35-134
Stock issued3.752.5565.70192002.660.751.69
Share buybacks0-5.7600
Cash from financing7.675.0871.214171-1.1360.759.1-3.96-22.9
Exchange rate effect0.110.38-0.810.42-0.020.25-1.460.42-1.881.19
Net change in cash2.071.652.62116-45.3-16.285.829-28.1
Free cash flow3.076.54-44.310.814.1-4.9-25.10.3638.675.4
Interest paid0.150.331.021.191.360.023.3512.113.213.1
Income taxes paid0.020.180.220.160.030.282.50.60.51.05

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $23.16 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin16.6%Gross profit / revenue.
Operating margin1.6%Operating income / revenue.
EBITDA margin2.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin1.7%Pre-tax income / revenue.
Net margin1.5%Net income / revenue.
FCF margin5.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin6.2%Cash from operations / revenue.
Effective tax rate11.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)5.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.5%Net income / average total assets.
Return on invested capital (ROIC)5.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue2.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.8%Capital expenditures / revenue.
D&A / revenue1.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y11.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y16.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y23.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y29.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y23.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y23.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y326.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y69.1%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y85.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y32.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y95.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y39.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y18.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y7.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y2.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y13.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y10.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y12.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y3.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y4.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.77xCurrent assets / current liabilities.
Quick ratio0.98x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.98x(Cash + short-term investments) / current liabilities.
Debt / equity0.26xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets11.5%Total debt / total assets.
Liabilities / assets56.0%Total liabilities / total assets.
Net debt-$291.6MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-7.36xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage2.28xOperating income / interest expense.
Working capital$314.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets6.7%(Goodwill + intangible assets) / total assets.
Tangible book value$347.7MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.63xRevenue / average total assets.
Fixed asset turnover15.0xRevenue / average property, plant and equipment.
Days payables3 days365 x average accounts payable / cost of revenue.
FCF conversion354.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow12.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.53Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$34.70Revenue / diluted weighted shares.
FCF per share$1.88Free cash flow / diluted weighted shares.
Operating cash flow per share$2.15Cash from operations / diluted weighted shares.
Book value per share$9.34Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$7.93Tangible book value / shares outstanding.
Cash per share$9.08(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$1.02BShare price x shares outstanding.
Enterprise value$724.5MMarket cap + total debt - cash - short-term investments.
P/E43.8xMarket cap / net income. Only when net income is positive.
P/S0.67xMarket cap / revenue.
P/B2.48xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.92xMarket cap / tangible book value, when positive.
P/FCF12.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF10.8xMarket cap / cash from operations, when positive.
EV/Sales0.48xEnterprise value / revenue.
EV/EBIT30.0xEnterprise value / operating income, when both are positive.
EV/EBITDA18.3xEnterprise value / EBITDA, when both are positive.
EV/FCF8.82xEnterprise value / free cash flow, when both are positive.
FCF yield8.1%Free cash flow / market cap.
Earnings yield2.3%Net income / market cap (the inverse of P/E).
What was TRUPANION, INC.'s revenue in fiscal 2025?

TRUPANION, INC. reported revenue of $1.44B for fiscal 2025, 11.9% higher than the year before.

Was TRUPANION, INC. profitable in fiscal 2025?

Yes. Net income was $19.4M, a net margin of 1.4%.

How much free cash flow did TRUPANION, INC. generate in fiscal 2025?

Cash from operations of $89.5M minus capital expenditures of $14.1M left free cash flow of $75.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TRUPANION, INC.